Attenuation of Diabetes-Induced Cardiac Inflammation and Pathological Remodeling by Low-Dose Radiation
Authors:
- Shunzi JinSJShunzi Jin
- Weiying GuoWGWeiying Guo
- Cai LiCLCai Li
- Xiaokun LiXLXiaokun Li
- Madhavi J. RaneMRMadhavi J. Rane
- Guanjun WangGWGuanjun Wang
- Lu CaiLCLu Cai
- 1 March 2011
- journal article
- Published by Radiation Research Society in Radiation Research
- Vol. 175 (3) , 307-321
Abstract
In the present study, novel preventive effects of repeated low-dose radiation exposure on diabetes-induced cardiac inflammation and cardiac damage were investigated. C57BL/6J mice were given multiple low doses of streptozotocin (STZ, 60 mg/kg × 6) to generate type 1 diabetes. A week after the last STZ injection, hyperglycemic mice were diagnosed and treated with and without whole-body low-dose radiation exposure (25 mGy X rays) once every 2 days for 2, 4, 8, 12 and 16 weeks. Diabetes caused significant increases in cardiac inflammation, shown by time-dependent increases in mRNA and protein expressions of interleukin 18 (IL-18), tumor necrosis factor-alpha (TNF-α), intercellular adhesion molecule 1 (ICAM-1), plasminogen activator inhibitor 1 (PAI-1), and monocyte chemoattractant protein 1 (MCP-1). Repeated exposure of control mice to low-dose radiation caused mild increases in these inflammatory factors, except for ICAM-1. Repeated exposure of diabetic mice to low-dose radiation significantly reduced diabetes-increased cardiac expression of IL-18, TNF-α, MCP-1 and PAI-1 at both the mRNA and protein levels. Furthermore, cardiac histopathological abnormalities, oxidative damage and fibrosis were significant in diabetic mice but to a lesser extent in diabetic mice with repeated low-dose radiation exposure. These results suggest that although low-dose radiation contributes to mild cardiac inflammation in control mice, it can significantly reduce diabetes-induced cardiac inflammation and associated pathological changes. Therefore, low-dose radiation may potentially become a novel approach to the prevention of diabetic cardiovascular complications.Keywords
This publication has 30 references indexed in Scilit:
- Role of MCP-1 in cardiovascular disease: molecular mechanisms and clinical implicationsClinical Science, 2009
- Inactivation of GSK-3β by Metallothionein Prevents Diabetes-Related Changes in Cardiac Energy Metabolism, Inflammation, Nitrosative Damage, and RemodelingDiabetes, 2009
- Cardioprotective and Anti-Inflammatory Effects of Interleukin Converting Enzyme Inhibition in Experimental Diabetic CardiomyopathyDiabetes, 2007
- Contributions of Inflammation and Cardiac Matrix Metalloproteinase Activity to Cardiac Failure in Diabetic CardiomyopathyDiabetes, 2007
- Chronic inhibition of p38MAPK improves cardiac and endothelial function in experimental diabetes mellitusEuropean Journal of Pharmacology, 2007
- Plasminogen activator inhibitor (PAI)-1 in vascular inflammation and thrombosisFrontiers in Bioscience-Landmark, 2007
- Inhibition of p38 mitogen-activated protein kinase attenuates left ventricular dysfunction by mediating pro-inflammatory cardiac cytokine levels in a mouse model of diabetes mellitusDiabetologia, 2006
- Molecular Targets of Diabetic Cardiovascular ComplicationsCurrent Drug Targets, 2005
- Oxidative Stress and Diabetic Cardiomyopathy: A Brief ReviewCardiovascular Toxicology, 2001
- Long-term effects of total-body irradiation on the kidney of Rhesus monkeysInternational Journal of Radiation Biology, 2000